Two Seas Capital LP
Two Seas Capital LP reported 52 holdings worth US$5.05B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 12, 2026
Two Seas Capital LP reported 52 holdings worth US$5.05B as of Jun 30, 2026. Largest: Roivant Sciences Ltd., Calumet, Inc and Core Scientific, Inc. Filed Aug 12, 2026 (Form 13F).
- Holdings
- 52
- Value as reported
- US$5.05B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Roivant Sciences Ltd. | 8.48M | US$300M | 5.9% |
| Calumet, Inc | 6.62M | US$238M | 4.7% |
| Core Scientific, Inc. | 9.03M | US$231M | 4.6% |
| Nektar Therapeutics | 3.09M | US$216M | 4.3% |
| Talen Energy Corporation | 507K | US$195M | 3.9% |
| Indivior Pharmaceuticals, Inc. | 3.48M | US$143M | 2.8% |
| Immunovant, Inc. | 3.15M | US$121M | 2.4% |
| Usa Today Co., Inc. | 14.1M | US$120M | 2.4% |
| Sharonai Holdings, Inc. | 1.29M | US$110M | 2.2% |
| Sotera Health Company | 5.84M | US$104M | 2.1% |
| Arbutus Biopharma Corporation | 19.1M | US$91.7M | 1.8% |
| Vistra Corp. | 431K | US$68.3M | 1.4% |
| Ftai Aviation Ltd. | 249K | US$67.4M | 1.3% |
| Terawulf Inc. | 2.49M | US$61.6M | 1.2% |
| Golar Lng Limited | 1.22M | US$60.9M | 1.2% |
| Echostar Corporation | 503K | US$51.1M | 1.0% |
| Cipher Digital Inc. | 2.04M | US$50M | 0.99% |
| Space Exploration Technologies Corp | 209K | US$35.7M | 0.71% |
| Abivax Sa | 245K | US$32.6M | 0.65% |
| Staar Surgical Company | 1.06M | US$30.5M | 0.60% |
| First Solar, Inc. | 128K | US$30.2M | 0.60% |
| Darling Ingredients Inc. | 517K | US$28.2M | 0.56% |
| Quantum Corporation | 2.49M | US$27.4M | 0.54% |
| Sable Offshore Corp. | 8.38M | US$25.8M | 0.51% |
| Bitdeer Technologies Group | 1.5M | US$23.8M | 0.47% |
| X-energy, Inc. | 1M | US$18.4M | 0.36% |
| Hut 8 Corp. | 158K | US$18.2M | 0.36% |
| Coreweave, Inc. | 153K | US$15.2M | 0.30% |
| Sonos, Inc. | 711K | US$9.61M | 0.19% |
| Lucid Diagnostics Inc. | 6M | US$6.42M | 0.13% |
| Odyssey Marine Exploration, Inc. | 5.59M | US$4.76M | 0.09% |
| Fermi Inc. | 353K | US$3.23M | 0.06% |
| Pavmed Inc. | 462K | US$2.74M | 0.05% |
| Esperion Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Transalta Corporation | 0 | US$0 | 0.00% |
Source
View original at SEC
Related